Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.
Hoda D, Richards R, Faber EA, Deol A, Hunter BD, Weber E, DiFilippo H, Henderson-Clark T, Meaux L, Crivera C, Riccobono C, Garrett A, Jackson CC, Fowler J, Theocharous P, Stewart R, Lorden AL, Porter DL, Berger A.
Hoda D, et al.
Future Oncol. 2022 Jun;18(19):2415-2431. doi: 10.2217/fon-2022-0162. Epub 2022 May 18.
Future Oncol. 2022.
PMID: 35583358
Free article.